| Literature DB >> 27270423 |
Y Zhen1,2,3, W Fang1,3, M Zhao3, R Luo1, Y Liu3, Q Fu3, Y Chen3, C Cheng3, Y Zhang4, Z Liu3,4.
Abstract
miR-374a has been reported to function as an oncogene during tumor pathogenesis. In this study, miR-374a is observed to reduce nasopharyngeal carcinoma (NPC) cell proliferation, migration, invasion, metastasis and cisplatin (DDP) resistance in vitro and in vivo. Mechanistic analyses indicate that miR-374a directly targets CCND1 to inactivate pPI3K/pAKT/c-JUN forming a negative feedback loop, as well as suppressing downstream signals related to cell cycle progression and epithelial-mesenchymal transition (EMT). Interestingly, we also observed that miR-374a direct targeting of CCND1 is modulated by tumor suppressor PDCD4 via suppressing pPI3K/pAKT/c-JUN signaling. In clinical specimens, miR-374a was positively and negatively correlated with expression of PDCD4 and CCND1, respectively. Our studies are the first to demonstrate that the miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop induced by PDCD4 supresses NPC cell growth, metastasis and chemotherapy resistance.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27270423 DOI: 10.1038/onc.2016.201
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867